Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced positive ...
AbCellera has an AI-driven antibody discovery platform, $650M liquidity, and an upcoming Phase 2 catalyst. Click here to read ...
11d
Here's What United Airlines Actually Spends Per Passenger On Its Polaris Business Class Amenities
United Airlines has spent years refining its Polaris business class product in an effort to remain competitive in the ...
Chevrolet has taken the covers off a new generation of the Silverado, which aims to put some daylight between itself and ...
TCW Emerging Markets Local Currency Income Fund, I Class returned -2.96% (net) for the first quarter of 2026, underperforming ...
Per May 2026 Type C meeting, AXPAXLI NDA for wet AMD to be based on SOL-1 Week 52 efficacy and safety plus interim SOL-R safety data Ocular to conduct interim SOL-R safety analysis in 4Q 2026 to reach ...
Ted Nesi ( [email protected]) is a Target 12 investigative reporter and 12 News politics/business editor. He co-hosts Newsmakers ...
VentureBeat surveyed 132 enterprise AI leaders: the production failure point isn't the model — it's the runtime layer most ...
Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of ...
Issued on behalf of Starfighters Space, Inc.A sector analysis of the commercial space economy — a once-niche corner of aerospace now racing ...
Mistral AI's OCR 4 delivers structured document intelligence with bounding boxes, confidence scores, and self-hosted ...
On Tuesday, federal prosecutors announced charges against 15 people in Minneapolis they say "conspired to impede or injure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results